Non‐Cancer Causes of Death in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Analysis
The Prostate · 2026-07 · 86 (10) · 1170-1173
DOI: 10.1002/pros.70174 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Prostate, online erschienen am 03.05.2026. Verfasst von Marta Garcia de Herreros und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital Clinic, Barcelona, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
As overall survival improves in metastatic hormone‐sensitive prostate cancer (mHSPC), non‐cancer causes of death are increasingly relevant.
Methods
We conducted a real‐world multicenter study of patients diagnosed with mHSPC treated with ADT alone or in combination. Causes of death before progression to castration‐resistant prostate cancer (CRPC) were classified as cancer‐ or non‐cancer‐related. Deaths were classified as non‐cancer‐related if they occurred in the absence of cancer progression.
Results
Among 565 patients, 35 (6.2%) died from non‐cancer‐related causes without disease progression, mainly infections (34%) and cardiovascular events (20%).
Conclusions
Non‐cancer mortality represents a meaningful proportion of deaths in mHSPC, supporting systematic cardiovascular risk evaluation and infection‐prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Department, Hospital Clinic, Barcelona, Spain.
- Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
- Department of Medicine, University of Barcelona, Barcelona, Spain.
- Radiation Oncology Department, Hospital Clinic, Barcelona, Spain.
- Urology Department, Hospital Clinic, Barcelona, Spain.
- Medical Oncology Department, Fundació Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, Spain.
Zitieren
APA
Garcia de Herreros, M., Rodrigo, C., Ferrer-Mileo, L., Fernández-Mañas, L., Mases, J., Diaz, N., Vilaseca, A., Altamirano, M., Gibanel, R., Ribal, M. J., Jimenez, N., Reig, O., Figols, M., Climent, M. Á., Font, A., & Mellado, B. (2026). Non‐Cancer Causes of Death in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Analysis. The Prostate, 86(10), 1170-1173. https://doi.org/10.1002/pros.70174
Vancouver
Garcia de Herreros M, Rodrigo C, Ferrer-Mileo L, Fernández-Mañas L, Mases J, Diaz N, et al. Non‐Cancer Causes of Death in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Analysis. The Prostate. 2026;86(10):1170-1173. doi:10.1002/pros.70174
BibTeX
@article{GarciadeHerreros2026,
author = {Garcia de Herreros, Marta and Rodrigo, Clara and Ferrer-Mileo, Laura and Fernández-Mañas, Laia and Mases, Joel and Diaz, Nely and Vilaseca, Antoni and Altamirano, Mariana and Gibanel, Roser and Ribal, Maria José and Jimenez, Natalia and Reig, Oscar and Figols, Mariona and Climent, Miguel Ángel and Font, Albert and Mellado, Begoña},
title = {Non‐Cancer Causes of Death in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Analysis},
journal = {The Prostate},
year = {2026},
volume = {86},
number = {10},
pages = {1170--1173},
doi = {10.1002/pros.70174}
}
EUVIMED